Recent APLT News
- Applied Therapeutics Added to Russell 3000® Index • GlobeNewswire Inc. • 07/01/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:29:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:28:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:25:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:17:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:07:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:25:21 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/05/2024 08:26:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/04/2024 08:31:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/17/2024 08:37:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/16/2024 10:10:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 11:17:44 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:13:13 AM
- Applied Therapeutics Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/09/2024 11:00:00 AM
- Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference • GlobeNewswire Inc. • 05/07/2024 11:00:00 AM
- Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer • GlobeNewswire Inc. • 04/15/2024 11:00:00 AM
- Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024 • GlobeNewswire Inc. • 04/04/2024 11:00:00 AM
- Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia • GlobeNewswire Inc. • 03/28/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 12:17:35 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/06/2024 12:19:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 12:12:11 PM
- Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results • GlobeNewswire Inc. • 03/06/2024 12:00:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/05/2024 10:42:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:18:44 PM
- Applied Therapeutics Announces $100 Million Private Placement • GlobeNewswire Inc. • 02/28/2024 01:05:00 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM